Howard Marks Alvotech Transaction History
Oaktree Capital Management LP
- $4.72 Billion
- Q3 2024
A detailed history of Howard Marks (Oaktree Capital Management LP) transactions in Alvotech stock. As of the latest transaction made, Oaktree Capital Management LP holds 2,532,027 shares of ALVO stock, worth $31.8 Million. This represents 0.64% of its overall portfolio holdings.
Number of Shares
2,532,027
Previous 2,532,027
-0.0%
Holding current value
$31.8 Million
Previous $30.8 Million
2.14%
% of portfolio
0.64%
Previous 0.61%
Shares
8 transactions
Others Institutions Holding ALVO
# of Institutions
32Shares Held
15.5MCall Options Held
0Put Options Held
0-
Vanguard Group Inc Valley Forge, PA3.17MShares$39.9 Million0.0% of portfolio
-
Bracebridge Capital, LLC2.71MShares$34 Million28.94% of portfolio
-
Morgan Stanley New York, NY1.74MShares$21.8 Million0.0% of portfolio
-
Littlejohn & CO LLC1.32MShares$16.6 Million6.38% of portfolio
-
Legal & General Group PLC London, X0997KShares$12.5 Million0.0% of portfolio
About Alvotech
- Ticker ALVO
- Exchange NASDAQ
- Sector Healthcare
- Industry Drug Manufacturers—Specialty & Generic
- Shares Outstandng 248,650,000
- Market Cap $3.12B
- Description
- Alvotech, through its subsidiaries, develops and manufactures biosimilar medicines for patients worldwide. It offers biosimilar products in the therapeutic areas of autoimmune, eye, and bone disorders, as well as cancer. The company's lead program is AVT02, a high concentration formulation biosimilar to Humira to treat various inflammatory condi...